On April 15-18 the 33rd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) took place in Copenhagen (Denmark). The congress counted over 15,000 registrations in a hybrid format, more than 150 sessions, and representatives of 146 countries.
ReAct's Andrea Caputo Svensson, Global Health Advisor and Maria Pränting, Scientific Coordinator attended the full program and shares three highlights.
GLG-ESCMID AMR Meeting
For the first time, the 33rd ECCMID was preceded by a high-level meeting in partnership with the Global Leaders Group (GLG) on Antimicrobial Resistance (AMR). The event, also live-streamed, featured a panel of keynote speakers, including:
- H.R.H. Crown Princess Mary Elizabeth, Crown Princess of Denmark
- H.E. Mia Amor Mottley, Prime Minister of Barbados and Chair of the GLG AMR
- H.E. Sophie Løhde, Minister of the Interior and Health of Denmark and
- Dr Tedros Adhanom Ghebreyesus, Director-General, World Health Organization
As the title of the event stated, “Forging partnerships between science and policy: A high-level antimicrobial resistance event”, the meeting placed the fundaments for an interactive and cooperative platform where scientists and policy makers can sit around the same table to address AMR-related issues and solutions.
ReAct welcomes this partnership and hopes for wider involvement of civil society organizations in upcoming congresses and high-level events, such as the 2024 UNGA High-level Meeting on Antimicrobial Resistance.
Civil society engagement and representation
Several sessions directly and indirectly referred to the important role that civil society has in the response to antimicrobial resistance, including their meaningful engagement for creating:
- political buy-in
- holding governments accountable, and
- identifying solutions that meet public health needs.
Among others, these two sessions strongly features this message:
“What can be learned from successful vertical programs to mitigate AMR” chaired by Haileyesus Getahun, WHO and Jyoti Joshi, ICARS. Featuring presentations from Claudia Denkinger, Heidelberg University Hospital and Kitty Van Weezenbeek, WHO
“Antibiotic drug shortages: causes and consequences” presented by Jennifer Cohn, GARDP and Esmita Charani, University of Cape Town
The constructive discussions between panelists, speakers, and participants highlighted the need for:
- wider civil society involvement
- building synergies with civil society active in other related fields
- increasing representation, especially from low-and middle-income countries
- sustainable financing of civil society organizations and
- stronger support from policy makers.
Gender and AMR
ReAct was pleased to see gender and equity taking centre stage in the session “How to incorporate gender in AMR”, arranged by ICARS and led by Esmita Charani, University of Cape Town, and Mirfin Mpundu, ReAct and ICARS.
The session dived into gender as a social construct, and how it influences research and health, as well as its impact on antimicrobial resistance and the lack of inclusivity in policy- and decision-making.
The speakers highlighted how gender and power imbalance are further exacerbated in low-and middle-income countries where minorities are severely challenged by:
- more stringent socio-cultural norms,
- low levels of education for women,
- limited health information and
- lack of adequate water, sanitation and hygiene facilities.
A full room of participants attended the session which sparked a constructive dialogue between the speakers and the audience, highlighting the need to mainstream gender in antimicrobial resistance through:
- gender-disaggregated data
- gender-sensitive polices
- inclusion of diversity of experiences and
- reduction of inequities while advancing global health goals.
It was also announced that there will be an ESCMID study group formed around the topic “Who are we leaving out?”. ReAct looks forward to see the outcomes of the work of this group.
More from "2023"
- New ReAct Brief: Antibiotic resistance is one of the greatest & most urgent cross-border health crises of our time – but still not addressed as such!
- 3 questions to MSF: Antimicrobial resistance in the ongoing Gaza war
- ReAct reports from the first AMR Multi-stakeholder Partnership Platform Plenary Assembly
- Workshop on community engagement on antibiotic resistance
- ReAct Asia Pacific: Youth engagement in India
- ReAct highlights World AMR Awareness Week 2023
- Latin America Empowered Communities: One Health meeting with diverse and hopeful voices
- Zambia: March for treatable infections during World AMR Awareness Week
- Release ReAct Africa Conference Report
- ReAct activities for World AMR Awareness Week 2023
- Join React Latin America Empowered Communities Meeting Series in November!
- Join ReAct webinar! AMR High-level Meeting 2024: Mobilizing Collective Action
- ReAct Report: Unlocking Barriers for Collective Action
- 5 reasons why the European Transferable Exclusivity Voucher proposal should go in the bin
- Alforja Educativa launched in Brazil!
- ReAct Asia Pacific: Engaging youth on AMR
- Antibiotic smart students and Teachers
- Key takeaways from the ReAct Africa & South Centre Conference 2023
- ART, BACTERIA AND THE MICROBIOME – A book launch in Ecuador
- Community engagement series – education and advocacy materials!
- Student Kyembe Ignitius Salachi
- ReAct is hiring! Are you our new Director for ReAct Asia Pacific?
- Strengthening Diagnostics Capacity: How can the newly adopted resolution help to contain the spread of antibiotic resistance?
- Almedalen 2023
- Join international dialogue on Art, Microbes and Planetary Health!
- Key achievements on antibiotic resistance during the Swedish EU Council Presidency
- ReAct Africa Conference 2023
- 3 reason why a new Pandemic Accord should address antibiotic resistance
- ReAct’s Impact Report 2019-2022!
- Ambitious new AMR recommendations adopted by EU Member States today
- 33rd ECCMID – ReAct’s highlights and impressions
- Uppsala Dialogue meeting: Experts from more than 20 countries gathered for collaborative actions on ABR
- ReAct Asia Pacific: Sensitizing civil society in India
- Sweden: International high-level meeting – unlocking barriers for collective action on antibiotic resistance
- Sweden’s successful approach to antibiotic resistance can be used as inspiration in other countries
- When Doctor Rianto suffered from antibiotic resistance as a patient
- ReAct Latin America: Cycling as community engagement
- Statement by ReAct – in response to the EC adoption of the revised pharmaceutical legislation proposal
- Mitigating AMR using implementation research: a development funder’s approach
- High-level conference in Japan: Universal Health Coverage, pandemic prevention, preparedness & response and AMR in focus
- New UNEP report – spotlight on environment and AMR
- New publication! Equitable access to antibiotics: A core element for pandemic preparedness and response
- Sustainable access to effective antibiotics in focus at Swedish EU presidency High-level meeting
- New ReAct Expert Policy Brief: 5 key challenges and public not-for-profit solutions in early stages antibiotics R&D
- Time is ticking – more needs to be done to tackle antibiotic resistance
- Sweden: Towards an antibiotic smart society
- Lancet article: Transferable exclusivity voucher: A flawed incentive to stimulate antibiotic innovation
- Lancet article: An analysis of existing national action plans for antimicrobial resistance – gaps and opportunities in strategies optimising antibiotic use in human populations
- New experts in the ReAct Toolbox Advisory Group!
- Dancing with bacteria: a theatrical performance about antibiotic resistance
- Malin Grape – Sweden’s AMR Ambassador on her role and the Swedish EU Presidency
- Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance
- Dr. Jaya Ranjalkar new Director ReAct Asia Pacific